BG
TTOO

Bollard Group’s T2 Biosystems, Inc TTOO Stock Holding History

Bollard Group’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$2K – 421
2022
Q1 		$2K Hold
1
– – ﹤0.01% 426
2021
Q4 		$2K Hold
1
– – ﹤0.01% 433
2021
Q3 		$3K Hold
1
– – ﹤0.01% 420
2021
Q2 		$3K Hold
1
– – ﹤0.01% 418
2021
Q1 		$5K Hold
1
– – ﹤0.01% 420
2020
Q4 		$4K Hold
1
– – ﹤0.01% 419
2020
Q3 		$4K Sell
1
-1
-50% -$7.41K ﹤0.01% 421
2020
Q2 		$15K Buy
+2
New +$8.49K ﹤0.01% 421

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bollard Group's TTOO Position: Q2 2022 in Review

Bollard Group sold out of T2 Biosystems, Inc (TTOO) in Q2 2022, closing a stake of 1 share — an estimated $2K sold.

Bollard Group first reported a position in TTOO in Q2 2020 and held it in 8 quarters. The position peaked at $15K in Q2 2020. 58 funds tracked by Wall St. Rank hold TTOO as of Q2 2022.

  • Bollard Group reported no remaining T2 Biosystems, Inc position as of Q2 2022 after selling out during the quarter.
  • Bollard Group sold 1 T2 Biosystems, Inc share in Q2 2022, an estimated $2K.
  • Bollard Group first reported a position in T2 Biosystems, Inc in Q2 2020 and held it in 8 quarters.
  • Bollard Group's T2 Biosystems, Inc position peaked at $15K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.